Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Survival Outcomes of Diffuse Large B Cell Lymphoma Beyond the Rituximab Era: Comprehensive Analysis of a Veteran Population within the Veterans Health Administration over 11 Years

Blood (2023) 142 (Supplement 1): 3785.

https://doi.org/10.1182/blood-2023-190048

Published: 2023

Journal Articles

Retrospective Analysis of Treatment Patterns and Outcomes in Geriatric Patients with Diffuse Large B-Cell Lymphoma (DLBCL) in the Veterans Health Administration (VHA)

Blood (2023) 142 (Supplement 1): 5156.

https://doi.org/10.1182/blood-2023-190571

Published: 2023

Journal Articles

Examining Racial Disparities in Diffuse Large B-Cell Lymphoma (DLBCL) Outcomes within the Veterans Health Administration (VHA)

Blood (2023) 142 (Supplement 1): 2398.

https://doi.org/10.1182/blood-2023-184997

Published: 2023

Journal Articles

Differences in Characteristics and Outcomes of Central Nervous System Versus Systemic Relapse after First Line Therapy in DLBCL Patients: A Veterans Health Administration (VHA) Study

Blood (2023) 142 (Supplement 1): 5161.

https://doi.org/10.1182/blood-2023-190641

Published: 2023

Journal Articles

Clinical Outcomes and Cardiovascular Adverse Events of Patients with Acute Myeloid Leukemia Treated with Venetoclax Plus a Hypomethylating Agent or Low-Dose Cytarabine in the Veterans Health Administration: A National Retrospective Cohort Study

Gabriel Roman Souza, Kana Tai Lucero, Ian Mines, Heidi Latiolais, Kathleen Franklin, Michael Mader, Zohra Nooruddin

Blood (2023) 142 (Supplement 1): 4235.

https://doi.org/10.1182/blood-2023-190526

Published: 2023

Journal Articles

Real-World Applications of Guideline Based Diagnostic and Treatment Patterns for Diffuse Large B-Cell Lymphoma within the Veterans Health Administration (VHA)

Blood (2023) 142 (Supplement 1): 3795.

https://doi.org/10.1182/blood-2023-187709

Published: 2023

Journal Articles

Shift in First-Line Therapies for United States Veterans Health Administration (VHA) Patients with Chronic Lymphocytic Leukemia (CLL) from 2014 to 2021

Kana Tai Lucero, Christopher R. Frei, Kellie J. Ryan, Obiageri O. Obodozie-Ofoegbu, Amanda M. Moore, Chengwen Teng, Xavier Jones, Zohra Nooruddin

Blood (2022) 140 (Supplement 1): 9915–9916.

https://doi.org/10.1182/blood-2022-163797

Published: 2022

Journal Articles

Survival Outcomes for High Risk Primary Refractory and Relapsed Large B-Cell Lymphoma (LBCL) within the Veterans Health Administration (VHA)

Blood (2022) 140 (Supplement 1): 9561–9563.

https://doi.org/10.1182/blood-2022-170661

Published: 2022

Journal Articles

Treatment Patterns and Survival Outcomes in Elderly Veterans Diagnosed with Diffuse Large B-Cell Lymphoma

Blood (2022) 140 (Supplement 1): 5195–5197.

https://doi.org/10.1182/blood-2022-171126

Published: 2022

Journal Articles

The Impact of Time from Diagnosis to Initiation of Chemotherapy on Survival of Patients with Diffuse Large B-Cell Lymphoma in the Veteran`s Health Administration

Blood (2022) 140 (Supplement 1): 2061–2062.

https://doi.org/10.1182/blood-2022-170576

Published: 2022

Journal Articles

Characteristics of Patients with Central Nervous System Relapse in Veterans with Diffuse Large B-Cell Lymphoma within the Veterans Health Administration

Amy M Horowitz, Madison H. Williams, Ryan A. Williams, Jean Pierre Blaize, Snegha Ananth, Michael M. Song, Brian Warnecke, Abhishek Pandya, Lakene Raissa Djoufack Djoumessi, Phillip Nazarewicz, Manuel Ricardo Espinoza-Gutarra, Juan J. Toro, Lindsey Lu, Kana Tai Lucero, Jennifer Whitehead, Kathleen Franklin, Michael Mader, Zohra Nooruddin

Blood (2021) 138 (Supplement 1): 2501.

https://doi.org/10.1182/blood-2021-147958

Published: 2021

Journal Articles

Uptake of Novel Agents (NAs) As First-Line Treatments for Black and White Patients with Chronic Lymphocytic Leukemia (CLL) in the Veterans Health Administration (VHA): A Retrospective Cohort Study

Kana Tai Lucero, Obiageri O. Obodozie-Ofoegbu, Zohra Nooruddin, Alyssa Castillo, Amanda M. Moore, Kellie J. Ryan, Xavier Jones, Christopher R. Frei

Blood (2021) 138 (Supplement 1): 340.

https://doi.org/10.1182/blood-2021-146860

Published: 2021

Journal Articles

A Retrospective Study of Hospice Enrollment in Patients with Diffuse Large B Cell Lymphoma within the Veterans Health Administration

Kana Tai Lucero, Madison H. Williams, Ryan A. Williams, Snegha Ananth, Jean Pierre Blaize, Michael M. Song, Brian Warnecke, Abhishek Pandya, Lakene Raissa Djoufack Djoumessi, Phillip Nazarewicz, Manuel Ricardo Espinoza-Gutarra, Juan J. Toro, Lindsey Lu, Jennifer Whitehead, Kathleen Franklin, Michael Mader, Zohra Nooruddin

Blood (2021) 138 (Supplement 1): 2517.

https://doi.org/10.1182/blood-2021-153278

Published: 2021

Journal Articles

Impact of Age on Treatment and Outcome in Newly Diagnosed DLBCL (Diffuse Large B-cell Lymphoma) Patients in the United States Veteran Population (2011-2017)

Snegha Ananth, MBBS, Madison H. Williams, MD, Ryan A. Williams, MD, Jean Pierre Blaize, MD, David Gregorio, DO, Michael M. Song, MDPhDPharmD, Gerardo Manuel Rosas, MD, Lakene Raissa Djoufack Djoumessi, MD, Brian Warnecke, DO, Abhishek Pandya, DO, Vivian Dee, NP, Michael Mader, MS, Juan J. Toro, MD MS, Kathleen Franklin, Phillip Nazarewicz, Zohra Nooruddin, MD

Blood (2020) 136 (Supplement 1): 1.

https://doi.org/10.1182/blood-2020-143206

Published: 2020

Journal Articles

Impact of Differences in Time from Diagnosis to Treatment on DLBCL Response and Survival Outcomes: A VA Study

Ryan A. Williams, MD, Madison H. Williams, MD, Jean Pierre Blaize, MD, Snegha Ananth, MBBS, David Gregorio, DO, Gerardo Manuel Rosas, MD, Michael M. Song, MDPhDPharmD, Brian Warnecke, DO, Abhishek Pandya, DO, Lakene Raissa Djoufack Djoumessi, MD, Vivian Dee, NP, Phillip Nazarewicz, Juan J. Toro, MD MS, Kathleen Franklin, Michael Mader, MS, Zohra Nooruddin, MD

Blood (2020) 136 (Supplement 1): 1–2.

https://doi.org/10.1182/blood-2020-143215

Published: 2020

Journal Articles

The Impact of Race and Ethnicity on Diffuse Large B-Cell Lymphoma (DLBCL) Outcomes within the Veterans Health Administration (VHA)

Madison H. Williams, MD, Ryan A. Williams, MD, Jean Pierre Blaize, MD, Snegha Ananth, MBBS, David Gregorio, DO, Gerardo Manuel Rosas, MD, Michael M. Song, MDPhDPharmD, Brian Warnecke, DO, Abhishek Pandya, DO, Lakene Raissa Djoufack Djoumessi, MD, Vivian Dee, NP, Phillip Nazarewicz, Kathleen Franklin, Juan J. Toro, MD MS, Michael Mader, MS, Zohra Nooruddin, MD

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-142118

Published: 2020

Journal Articles

Treatment Patterns and Outcomes of 1205 Patients on Novel Agents in the US Veterans Health Administration (VHA) System: Results from the Largest Retrospective EMR and Chart Review Study in the Real-World Setting

Christopher R Frei, Hannah Le, PharmD, MPH, Daniel McHugh, Cynthia Elesinmogun, PharmD, Samantha Galley, Kathleen Franklin, Juan Tavera, Michelle Janania Martinez, MD, David J Gregorio, DO, Snegha Ananth, MBBS, Ricardo Uribe, Prathibha Surapaneni, Manuel Ricardo Espinoza-Gutarra, MD, Michael Song, Xavier Jones, Chengwen Teng, Obiageri O Obodozie-Ofoegbu, Zohra Nooruddin, MD

Blood (2019) 134 (Supplement_1): 795.

https://doi.org/10.1182/blood-2019-122434

Published: 2019

Journal Articles

Veterans Treated with R-CHOP for Diffuse Large B Cell Lymphoma Compared to Neighboring Hospital: An Interesting Discovery for Treatment Outcomes

Jessica Trevino Jones, MD, Manuel Ricardo Espinoza-Gutarra, MD, Sushanth Kakarla, MBBS, Michelle Janania Martinez, MD, David Gregorio, MD, Prathibha Surapaneni, Michael Mader, Zohra Nooruddin, MD

Blood (2018) 132 (Supplement 1): 3604.

https://doi.org/10.1182/blood-2018-99-119667

Published: 2018

Journal Articles

Post-Transplant Diffuse Large B Cell Lymphoma with Non Germinal Center B-Cell Subtype Frequently Lacks Programmed Cell Death Ligand (PD-L1) Overexpression Which May Influence Overall Outcomes

Zohra Nooruddin, MD, Zenggang Pan, MD PhD, Lilyana Gross, Weitzenkamp David, Bradley M. Haverkos, MD MPH, MS, Daniel A Pollyea, MD, Jonathan A Gutman, MD, William Robinson, MD PhD, Clayton Smith, MD FRCPC, Jeffrey Schowinsky, MD, Purev Enkhtsetseg, MD, Daniel W. Sherbenou, MD PhD, Rachel Rabinovitch, MD, Douglas Ney, MD, Craig T Jordan, PhD, Manali Kamdar, MD

Blood (2016) 128 (22): 3054.

https://doi.org/10.1182/blood.V128.22.3054.3054

Published: 2016

Journal Articles

IHC Analysis and Prognostic Factors in Post Transplant Lymphoproliferative Disorders after Solid Organ Transplantation: A Single Center Experience

Zohra Nooruddin, MD, William Robinson, MD PhD, Daniel Pollyea, MD MS, Jonathan A Gutman, MD, Clayton Smith, MD FRCPC, Zenggang Pan, MD, Craig T Jordan, PhD, Rachel Rabinovitch, MD, Jeffrey Schowinsky, Xian Lu, PhD, Douglas Ney, MD, Manali Kamdar, MD

Blood (2015) 126 (23): 1443.

https://doi.org/10.1182/blood.V126.23.1443.1443

Published: 2015

NARROW

Survival Outcomes of Diffuse Large B Cell Lymphoma Beyond the Rituximab Era: Comprehensive Analysis of a Veteran Population within the Veterans Health Administration over 11 Years

Retrospective Analysis of Treatment Patterns and Outcomes in Geriatric Patients with Diffuse Large B-Cell Lymphoma (DLBCL) in the Veterans Health Administration (VHA)

Examining Racial Disparities in Diffuse Large B-Cell Lymphoma (DLBCL) Outcomes within the Veterans Health Administration (VHA)

Differences in Characteristics and Outcomes of Central Nervous System Versus Systemic Relapse after First Line Therapy in DLBCL Patients: A Veterans Health Administration (VHA) Study

Clinical Outcomes and Cardiovascular Adverse Events of Patients with Acute Myeloid Leukemia Treated with Venetoclax Plus a Hypomethylating Agent or Low-Dose Cytarabine in the Veterans Health Administration: A National Retrospective Cohort Study

Real-World Applications of Guideline Based Diagnostic and Treatment Patterns for Diffuse Large B-Cell Lymphoma within the Veterans Health Administration (VHA)

Shift in First-Line Therapies for United States Veterans Health Administration (VHA) Patients with Chronic Lymphocytic Leukemia (CLL) from 2014 to 2021

Survival Outcomes for High Risk Primary Refractory and Relapsed Large B-Cell Lymphoma (LBCL) within the Veterans Health Administration (VHA)

Treatment Patterns and Survival Outcomes in Elderly Veterans Diagnosed with Diffuse Large B-Cell Lymphoma

The Impact of Time from Diagnosis to Initiation of Chemotherapy on Survival of Patients with Diffuse Large B-Cell Lymphoma in the Veteran`s Health Administration

Characteristics of Patients with Central Nervous System Relapse in Veterans with Diffuse Large B-Cell Lymphoma within the Veterans Health Administration

Uptake of Novel Agents (NAs) As First-Line Treatments for Black and White Patients with Chronic Lymphocytic Leukemia (CLL) in the Veterans Health Administration (VHA): A Retrospective Cohort Study

A Retrospective Study of Hospice Enrollment in Patients with Diffuse Large B Cell Lymphoma within the Veterans Health Administration

Impact of Age on Treatment and Outcome in Newly Diagnosed DLBCL (Diffuse Large B-cell Lymphoma) Patients in the United States Veteran Population (2011-2017)

Impact of Differences in Time from Diagnosis to Treatment on DLBCL Response and Survival Outcomes: A VA Study

The Impact of Race and Ethnicity on Diffuse Large B-Cell Lymphoma (DLBCL) Outcomes within the Veterans Health Administration (VHA)

Treatment Patterns and Outcomes of 1205 Patients on Novel Agents in the US Veterans Health Administration (VHA) System: Results from the Largest Retrospective EMR and Chart Review Study in the Real-World Setting

Veterans Treated with R-CHOP for Diffuse Large B Cell Lymphoma Compared to Neighboring Hospital: An Interesting Discovery for Treatment Outcomes

Post-Transplant Diffuse Large B Cell Lymphoma with Non Germinal Center B-Cell Subtype Frequently Lacks Programmed Cell Death Ligand (PD-L1) Overexpression Which May Influence Overall Outcomes

IHC Analysis and Prognostic Factors in Post Transplant Lymphoproliferative Disorders after Solid Organ Transplantation: A Single Center Experience

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only